Dinglan Wu Selected Research

Paclitaxel (Taxol)

1/2020

Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dinglan Wu Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 12/2014
19	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2008
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 11/2017
3	Glioma (Gliomas) 01/2023 - 04/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 04/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2018
2	Carcinogenesis 01/2022 - 01/2018
2	Hypoxia (Hypoxemia) 12/2014 - 05/2014
1	Epstein-Barr Virus Infections 04/2024
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2014
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 01/2018
6	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2013
5	AndrogensIBA 01/2021 - 01/2016
5	Orphan Nuclear ReceptorsIBA 01/2021 - 05/2015
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2014
3	Cofilin 1IBA 01/2019 - 11/2017
2	Androgen Antagonists (Antiandrogens)IBA 01/2022 - 01/2013
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 01/2013
2	LigandsIBA 01/2021 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
1	InterferonsIBA 04/2024
1	CholesterolIBA 01/2023
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	AntigensIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	IronIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	ezrinIBA 04/2020
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2020
1	XenobioticsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	sipuleucel-T (APC8015)FDA Link 01/2020
1	LuciferasesIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	ElementsIBA 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	EnzymesIBA 01/2018
1	Abiraterone AcetateIBA 01/2018
1	abirateroneIBA 01/2018
1	AgarIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 11/2017
1	Small Interfering RNA (siRNA)IBA 11/2017
1	Actin Depolymerizing Factors (Cofilins)IBA 11/2017
1	CytokinesIBA 08/2017
1	Sirtuin 1IBA 05/2015
1	Ion Channels (Ion Channel)IBA 12/2014
1	Hormones (Hormone)IBA 01/2013
1	bicalutamide (Casodex)FDA LinkGeneric 01/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2008

Therapy/Procedure

10	Castration 01/2023 - 01/2018
5	Therapeutics 01/2023 - 01/2020
2	Immunotherapy 01/2022 - 01/2020